SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS

平滑肌细胞增殖和动脉粥样硬化

基本信息

  • 批准号:
    2222503
  • 负责人:
  • 金额:
    $ 17.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-08-16 至 1998-07-31
  • 项目状态:
    已结题

项目摘要

Atherosclerosis is a complex pathological process that results from an interplay of genetic and environmental components. Many human beings develop accelerated atherosclerosis in the absence of known risk factors, and it has been proposed that some individuals may be genetically predisposed to develop atherosclerosis as a result of mechanisms Operating at the level of the arterial wall. Proliferation of smooth muscle cells in the arterial intima is of key importance in the development and growth of atherosclerotic lesions. In the proposed studies the hypothesis to be tested is that genetic susceptibility to atherosclerosis at the artery wall level includes a differential proliferative response of smooth muscle cells manifested through a regulatory molecule heparan sulfate proteoglycan (HSPG). The studies are possible because of the availability of genetically selected atherosclerosis-susceptible White Carneau (WC) and -resistant Show Racer (SR) pigeons. Cultured aortic smooth muscle cells of the WC pigeons demonstrate a greater proliferation capacity than those of SR. Studies of cell surface HSPG have demonstrated reduced HSPG in WC compared to SR cells. The HSPG remaining on the surface of WC have low sulfated octasaccharide and possess a low content of a unique disaccharide containing iduronic acid 2-O-SO3. When WC HSPG are isolated and added to WC or SR smooth muscle cells in culture, a low antiproliferative effect is observed. SR HSPG block the proliferation of SR cells and are less effective in WC cells. The studies proposed are designed to determine the mechanisms that result in reduced HSPG on WC cells. Based on preliminary work, WC cells produce a pool of cell surface HSPG which is transported to the cell surface but rapidly lost. Possible roles of heparanases and proteinases in this loss will be explored in cell culture studies to define a mechanism that may be unique to the WC cells. Through pulse chase and kinetic modeling, the metabolism and cellular pathways involved in the fast-turning-over pool of HSPG will be examined. Studies of oligosaccharides of cell surface HSPG indicated that the reduced antiproliferative effect of HSPG resulted from the alterations in oligosaccharide sequences and secondary modifications (e.g., sulfation and position). Proposed studies will examine the activity of N-deacetylase/N sulfotransferase, the pivotal enzyme in the production of sulfated oligosaccharide blocks in HS to determine if structural variations in the saccharides of WC HS are attributed to differential enzyme activity. The ultimate goal of the proposal is to determine the role of HSPG in relation to smooth muscle cell proliferation in atherosclerosis and conditions such as restenosis following clinical angioplasty.
动脉粥样硬化是一种复杂的病理过程

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM D WAGNER其他文献

WILLIAM D WAGNER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM D WAGNER', 18)}}的其他基金

SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
  • 批准号:
    2222502
  • 财政年份:
    1991
  • 资助金额:
    $ 17.14万
  • 项目类别:
SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
  • 批准号:
    2459966
  • 财政年份:
    1991
  • 资助金额:
    $ 17.14万
  • 项目类别:
SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
  • 批准号:
    3364914
  • 财政年份:
    1991
  • 资助金额:
    $ 17.14万
  • 项目类别:
SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
  • 批准号:
    3364913
  • 财政年份:
    1991
  • 资助金额:
    $ 17.14万
  • 项目类别:
SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
  • 批准号:
    3364915
  • 财政年份:
    1991
  • 资助金额:
    $ 17.14万
  • 项目类别:
SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
  • 批准号:
    2222504
  • 财政年份:
    1991
  • 资助金额:
    $ 17.14万
  • 项目类别:
AORTIC PROTEOGLYCANS AND ATHEROSCLEROSIS
主动脉蛋白聚糖和动脉粥样硬化
  • 批准号:
    3337976
  • 财政年份:
    1979
  • 资助金额:
    $ 17.14万
  • 项目类别:
AORTIC PROTEOGLYCANS AND ATHEROSCLEROSIS
主动脉蛋白聚糖和动脉粥样硬化
  • 批准号:
    3337975
  • 财政年份:
    1979
  • 资助金额:
    $ 17.14万
  • 项目类别:
AORTIC PROTEOGLYCANS AND ATHEROSCLEROSIS
主动脉蛋白聚糖和动脉粥样硬化
  • 批准号:
    2215812
  • 财政年份:
    1979
  • 资助金额:
    $ 17.14万
  • 项目类别:
AORTIC PROTEOGLYCANS AND ATHEROSCLEROSIS
主动脉蛋白聚糖和动脉粥样硬化
  • 批准号:
    3337969
  • 财政年份:
    1979
  • 资助金额:
    $ 17.14万
  • 项目类别:

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 17.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
  • 批准号:
    23K15842
  • 财政年份:
    2023
  • 资助金额:
    $ 17.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
  • 批准号:
    2880683
  • 财政年份:
    2023
  • 资助金额:
    $ 17.14万
  • 项目类别:
    Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 17.14万
  • 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 17.14万
  • 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
  • 批准号:
    10589484
  • 财政年份:
    2023
  • 资助金额:
    $ 17.14万
  • 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
  • 批准号:
    10585070
  • 财政年份:
    2023
  • 资助金额:
    $ 17.14万
  • 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
  • 批准号:
    10570469
  • 财政年份:
    2023
  • 资助金额:
    $ 17.14万
  • 项目类别:
2023 Atherosclerosis
2023 动脉粥样硬化
  • 批准号:
    10675221
  • 财政年份:
    2023
  • 资助金额:
    $ 17.14万
  • 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
  • 批准号:
    10619831
  • 财政年份:
    2023
  • 资助金额:
    $ 17.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了